Spinal meningiomas, from biology to management - A literature review
Frontiers in Oncology · 13.01.2023 · 12
DOI: 10.3389/fonc.2022.1084404 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 13.01.2023. Verfasst von Nicolas Serratrice und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut de la Colonne Vertébrale et des Neurosciences (ICVNS), Centre Médico-Chirurgical Bizet, Paris, France. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Meningiomas arise from arachnoidal cap cells of the meninges, constituting the most common type of central nervous system tumors, and are considered benign tumors in most cases. Their incidence increases with age, and they mainly affect females, constituting 25-46% of primary spinal tumors. Spinal meningiomas could be detected incidentally or be unraveled by various neurological symptoms ( e.g. , back pain, sphincter dysfunction, sensorimotor deficits). The gold standard diagnostic modality for spinal meningiomas is Magnetic resonance imaging (MRI) which permits their classification into four categories based on their radiological appearance. According to the World Health Organization (WHO) classification, the majority of spinal meningiomas are grade 1. Nevertheless, they can be of higher grade (grades 2 and 3) with atypical or malignant histology and a more aggressive course. To date, surgery is the best treatment where the big majority of meningiomas can be cured. Advances in surgical techniques (ultrasonic dissection, microsurgery, intraoperative monitoring) increase the complete resection rate. Operated patients have a satisfactory prognosis, even in those with poor preoperative neurological status. Adjuvant therapy has a growing role in treating spinal meningiomas, mainly in the case of subtotal resection and tumor recurrence. The current paper reviews the fundamental epidemiological and clinical aspects of spinal meningiomas, their histological and genetic characteristics, and their management, including the various surgical novelties and techniques.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut de la Colonne Vertébrale et des Neurosciences (ICVNS), Centre Médico-Chirurgical Bizet, Paris, France.
- EA 4391, Excitabilité Nerveuse et Thérapeutique, Faculté de Santé, Université Paris Est, Créteil, France.
- Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
- Service de Neurochirurgie, Centre Hospitalier de la Côte Basque, Bayonne, France.
- Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
- Institut de Chirurgie Osseuse et de Neurochirurgie, Médipole-Montagard, Avignon, France.
Förderung
- NCI NIH HHS
Zitieren
APA
Serratrice, N., Lameche, I., Attieh, C., Chalah, M. A., Faddoul, J., Tarabay, B., Bou-Nassif, R., Ali, Y., Mattar, J. G., Nataf, F., Ayache, S. S., & Abi Lahoud, G. N. (2023). Spinal meningiomas, from biology to management - A literature review. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.1084404
Vancouver
Serratrice N, Lameche I, Attieh C, Chalah MA, Faddoul J, Tarabay B, et al. Spinal meningiomas, from biology to management - A literature review. Frontiers in Oncology. 2023;12. doi:10.3389/fonc.2022.1084404
BibTeX
@article{Serratrice2023,
author = {Serratrice, Nicolas and Lameche, Imène and Attieh, Christian and Chalah, Moussa A and Faddoul, Joe and Tarabay, Bilal and Bou-Nassif, Rabih and Ali, Youssef and Mattar, Joseph G and Nataf, François and Ayache, Samar S and Abi Lahoud, Georges N},
title = {Spinal meningiomas, from biology to management - A literature review},
journal = {Frontiers in Oncology},
year = {2023},
volume = {12},
doi = {10.3389/fonc.2022.1084404}
}
EUVIMED